The State Service of Ukraine on Medicines and Drugs Control keeps working in quarantine conditions till 31 August 2020

Опубліковано 31.07.2020 о 11:45

 

 

The quarantine has been extended till 31 August 2020 in all areas of Ukraine, according to the Resolution of the Cabinet of Ministers of Ukraine of 22.07.2020 № 641 “On the introduction of quarantine and the stepping up anti-epidemic measures in the area with a significant spread of acute respiratory disease COVID-19 caused by coronavirus SARS-CoV-2”.

 

Work schedule of the State Service of Ukraine on Medicines and Drugs Control for the period of quarantine 

 

Mon – Thu

 

08:00 – 17:00

Fri

08:00 – 15:45

 

Break

12:00 – 12:45

Sat – Sun

Weekend

 

 PAY ATTENTION

Citizens may request the State Service of Ukraine on Medicines and Drugs Control via:

– official email dls@dls.gov.ua;

– link on the official website of the State Service of Ukraine on Medicines and Drugs Control https://www.dls.gov.ua;

– website – to apply for approval documents and track applications https://e-services.dls.gov.ua.

Business entities are advised to prefer electronic means of communication while reaching the State Service of Ukraine on Medicines and Drugs Control regarding the status of processing requests, providing administrative services, their payments and registration of official correspondence:

– official email of the State Service of Ukraine on Medicines and Drugs Control dls@dls.gov.ua;

– official emails of the employees mentioned in the section of the website “SMDC – Contacts”

Business entities may also track their online applications submitted to the State Service of Ukraine on Medicines and Drugs Control via the following link https://e-services.dls.gov.ua.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Print button Версія для друку

Попередня

To attention of business entities carrying out economic activity on cultivation of the plants included into the table I of the list

Наступна

Working group on mainstreaming of the Register of individuals responsible for introduction into circulation medicinal products, active implantable medical devices, in vitro diagnostic medical devices